[1]
“The Potential of eCD4-Ig, Delivered by Adeno-Associated Virus (AAV) Vector as a Novel Vaccine for HIV/AIDS Infection”, SCRIPTA SCORE Sci Med J., vol. 2, no. 2, pp. 133–9, Feb. 2021, doi: 10.32734/scripta.v2i2.3922.